Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Garmo

Showing results (51-60 of 261) with videos related to

Pageof 27
Sort By:
BJUI Compass|July 14, 2026
Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosisMarcus Westerberg, Rolf Gedeborg, Hans Garmo, et al.
Cancer Causes & Control : CCC|June 21, 2011
Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancerMats Lambe, Annette Wigertz, Hans Garmo, et al.
American Journal of Epidemiology|May 19, 2021
Comparison of Relative Survival and Cause-Specific Survival in Men With Prostate Cancer According to Age and Risk Category: A Nationwide, Population-Based StudyAndri Wilberg Orrason, Hans Garmo, Johan Styrke, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Improved clinical outcome after acute myocardial infarction in hospitals participating in a Swedish quality improvement initiativeRickard Carlhed, Mats Bojestig, Anette Peterson, et al.
JAMA Network Open|June 4, 2024
Natural History of Nonmetastatic Prostate Cancer Managed With Watchful WaitingEugenio Ventimiglia, Rolf Gedeborg, Johan Styrke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 2025
Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in SwedenE Lin, Hans Garmo, Kerri Beckmann, et al.
BMJ Open|December 26, 2019
Determinants for choosing and adhering to active surveillance for localised prostate cancer: a nationwide population-based studyOskar Bergengren, Hans Garmo, Ola Bratt, et al.
Cancer|June 8, 2012
Primary cancers before and after prostate cancer diagnosisMieke Van Hemelrijck, Linda Drevin, Lars Holmberg, et al.
BMJ (Clinical Research Ed.)|June 20, 2013
Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control studyDavid Robinson, Hans Garmo, Anna Bill-Axelson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 6, 2008
Low-dose hypersensitive gammaH2AX response and infrequent apoptosis in epidermis from radiotherapy patientsMartin Simonsson, Fredrik Qvarnström, Jan Nyman, et al.
Pageof 27

Showing results (51-60 of 261) with videos related to

Sort By:
Pageof 27
BJUI Compass|July 14, 2026
Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosisMarcus Westerberg, Rolf Gedeborg, Hans Garmo, et al.
Cancer Causes & Control : CCC|June 21, 2011
Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancerMats Lambe, Annette Wigertz, Hans Garmo, et al.
American Journal of Epidemiology|May 19, 2021
Comparison of Relative Survival and Cause-Specific Survival in Men With Prostate Cancer According to Age and Risk Category: A Nationwide, Population-Based StudyAndri Wilberg Orrason, Hans Garmo, Johan Styrke, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Improved clinical outcome after acute myocardial infarction in hospitals participating in a Swedish quality improvement initiativeRickard Carlhed, Mats Bojestig, Anette Peterson, et al.
JAMA Network Open|June 4, 2024
Natural History of Nonmetastatic Prostate Cancer Managed With Watchful WaitingEugenio Ventimiglia, Rolf Gedeborg, Johan Styrke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 2025
Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in SwedenE Lin, Hans Garmo, Kerri Beckmann, et al.
BMJ Open|December 26, 2019
Determinants for choosing and adhering to active surveillance for localised prostate cancer: a nationwide population-based studyOskar Bergengren, Hans Garmo, Ola Bratt, et al.
Cancer|June 8, 2012
Primary cancers before and after prostate cancer diagnosisMieke Van Hemelrijck, Linda Drevin, Lars Holmberg, et al.
BMJ (Clinical Research Ed.)|June 20, 2013
Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control studyDavid Robinson, Hans Garmo, Anna Bill-Axelson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 6, 2008
Low-dose hypersensitive gammaH2AX response and infrequent apoptosis in epidermis from radiotherapy patientsMartin Simonsson, Fredrik Qvarnström, Jan Nyman, et al.
Pageof 27